NAPHT-2-YLACETIC ACID DERIVATIVES TO TREAT AIDS

The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIANHONG XU, JAMES TAYLOR, MICHAEL L. MITCHELL, HONGYAN GUO, PAUL A. ROETHLE, JAMES D. TRENKLE, RANDALL W. VIVIAN, RANDALL L. HALCOMB, KERIM BABAOGLU, JOHN O. LINK, RYAN MCFADDEN, KYLA BJORNSON, HONGTAO LIU, PAUL HRVATIN, ELIZABETH BACON
Format: Patent
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LIANHONG XU
JAMES TAYLOR
MICHAEL L. MITCHELL
HONGYAN GUO
PAUL A. ROETHLE
JAMES D. TRENKLE
RANDALL W. VIVIAN
RANDALL L. HALCOMB
KERIM BABAOGLU
JOHN O. LINK
RYAN MCFADDEN
KYLA BJORNSON
HONGTAO LIU
PAUL HRVATIN
ELIZABETH BACON
description The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds of formula (I).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT2588450TT</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT2588450TT</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT2588450TT3</originalsourceid><addsrcrecordid>eNrjZND3cwzwCNE10o30cXR2DfF0VnB09nRRcHEN8gxzDPEMcw1WCPFXCAlydQxRcPR0CeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEBIUamFhYmpgYhIcZEKAEApQcl2A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NAPHT-2-YLACETIC ACID DERIVATIVES TO TREAT AIDS</title><source>esp@cenet</source><creator>LIANHONG XU ; JAMES TAYLOR ; MICHAEL L. MITCHELL ; HONGYAN GUO ; PAUL A. ROETHLE ; JAMES D. TRENKLE ; RANDALL W. VIVIAN ; RANDALL L. HALCOMB ; KERIM BABAOGLU ; JOHN O. LINK ; RYAN MCFADDEN ; KYLA BJORNSON ; HONGTAO LIU ; PAUL HRVATIN ; ELIZABETH BACON</creator><creatorcontrib>LIANHONG XU ; JAMES TAYLOR ; MICHAEL L. MITCHELL ; HONGYAN GUO ; PAUL A. ROETHLE ; JAMES D. TRENKLE ; RANDALL W. VIVIAN ; RANDALL L. HALCOMB ; KERIM BABAOGLU ; JOHN O. LINK ; RYAN MCFADDEN ; KYLA BJORNSON ; HONGTAO LIU ; PAUL HRVATIN ; ELIZABETH BACON</creatorcontrib><description>The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds of formula (I).</description><language>eng ; por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170803&amp;DB=EPODOC&amp;CC=PT&amp;NR=2588450T$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170803&amp;DB=EPODOC&amp;CC=PT&amp;NR=2588450T$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIANHONG XU</creatorcontrib><creatorcontrib>JAMES TAYLOR</creatorcontrib><creatorcontrib>MICHAEL L. MITCHELL</creatorcontrib><creatorcontrib>HONGYAN GUO</creatorcontrib><creatorcontrib>PAUL A. ROETHLE</creatorcontrib><creatorcontrib>JAMES D. TRENKLE</creatorcontrib><creatorcontrib>RANDALL W. VIVIAN</creatorcontrib><creatorcontrib>RANDALL L. HALCOMB</creatorcontrib><creatorcontrib>KERIM BABAOGLU</creatorcontrib><creatorcontrib>JOHN O. LINK</creatorcontrib><creatorcontrib>RYAN MCFADDEN</creatorcontrib><creatorcontrib>KYLA BJORNSON</creatorcontrib><creatorcontrib>HONGTAO LIU</creatorcontrib><creatorcontrib>PAUL HRVATIN</creatorcontrib><creatorcontrib>ELIZABETH BACON</creatorcontrib><title>NAPHT-2-YLACETIC ACID DERIVATIVES TO TREAT AIDS</title><description>The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds of formula (I).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND3cwzwCNE10o30cXR2DfF0VnB09nRRcHEN8gxzDPEMcw1WCPFXCAlydQxRcPR0CeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEBIUamFhYmpgYhIcZEKAEApQcl2A</recordid><startdate>20170803</startdate><enddate>20170803</enddate><creator>LIANHONG XU</creator><creator>JAMES TAYLOR</creator><creator>MICHAEL L. MITCHELL</creator><creator>HONGYAN GUO</creator><creator>PAUL A. ROETHLE</creator><creator>JAMES D. TRENKLE</creator><creator>RANDALL W. VIVIAN</creator><creator>RANDALL L. HALCOMB</creator><creator>KERIM BABAOGLU</creator><creator>JOHN O. LINK</creator><creator>RYAN MCFADDEN</creator><creator>KYLA BJORNSON</creator><creator>HONGTAO LIU</creator><creator>PAUL HRVATIN</creator><creator>ELIZABETH BACON</creator><scope>EVB</scope></search><sort><creationdate>20170803</creationdate><title>NAPHT-2-YLACETIC ACID DERIVATIVES TO TREAT AIDS</title><author>LIANHONG XU ; JAMES TAYLOR ; MICHAEL L. MITCHELL ; HONGYAN GUO ; PAUL A. ROETHLE ; JAMES D. TRENKLE ; RANDALL W. VIVIAN ; RANDALL L. HALCOMB ; KERIM BABAOGLU ; JOHN O. LINK ; RYAN MCFADDEN ; KYLA BJORNSON ; HONGTAO LIU ; PAUL HRVATIN ; ELIZABETH BACON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT2588450TT3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LIANHONG XU</creatorcontrib><creatorcontrib>JAMES TAYLOR</creatorcontrib><creatorcontrib>MICHAEL L. MITCHELL</creatorcontrib><creatorcontrib>HONGYAN GUO</creatorcontrib><creatorcontrib>PAUL A. ROETHLE</creatorcontrib><creatorcontrib>JAMES D. TRENKLE</creatorcontrib><creatorcontrib>RANDALL W. VIVIAN</creatorcontrib><creatorcontrib>RANDALL L. HALCOMB</creatorcontrib><creatorcontrib>KERIM BABAOGLU</creatorcontrib><creatorcontrib>JOHN O. LINK</creatorcontrib><creatorcontrib>RYAN MCFADDEN</creatorcontrib><creatorcontrib>KYLA BJORNSON</creatorcontrib><creatorcontrib>HONGTAO LIU</creatorcontrib><creatorcontrib>PAUL HRVATIN</creatorcontrib><creatorcontrib>ELIZABETH BACON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIANHONG XU</au><au>JAMES TAYLOR</au><au>MICHAEL L. MITCHELL</au><au>HONGYAN GUO</au><au>PAUL A. ROETHLE</au><au>JAMES D. TRENKLE</au><au>RANDALL W. VIVIAN</au><au>RANDALL L. HALCOMB</au><au>KERIM BABAOGLU</au><au>JOHN O. LINK</au><au>RYAN MCFADDEN</au><au>KYLA BJORNSON</au><au>HONGTAO LIU</au><au>PAUL HRVATIN</au><au>ELIZABETH BACON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NAPHT-2-YLACETIC ACID DERIVATIVES TO TREAT AIDS</title><date>2017-08-03</date><risdate>2017</risdate><abstract>The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds of formula (I).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; por
recordid cdi_epo_espacenet_PT2588450TT
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NAPHT-2-YLACETIC ACID DERIVATIVES TO TREAT AIDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T21%3A04%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIANHONG%20XU&rft.date=2017-08-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT2588450TT%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true